SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 100.49-1.0%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Luke who wrote (633)5/14/1998 3:03:00 AM
From: Rocketman  Read Replies (1) of 3202
 
You don't get a clone "Reagent" unless you sign a licensing agreement that goes beyond the terms of the database subscription. These include the royalties and milestones payments. The dbase deals get you access to computer data only. If I recall correctly, they had 6000 of these deals signed by January of this year, up from 2000 at the annual meeting last spring. Like any kind of exploration, I would expect most of these to be dry holes, but the strikes could bring in significant future cash. Policing any kind of patent or contract is always a hairy issue, but the big Pharmas are probably more interested in long term relationships than trying to rip you off on a one time deal.

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News